The Trump administration's recent travel and visa restrictions have left some hospitals in the United States without essential staff.

Measles cases in the United States have reached their highest level in 25 years, with more than 1,270 confirmed cases this year.

The National Institutes of Health announced it will put a limit on publisher fees for publicly funded research by Fiscal Year 2026.

A new malaria treatment has been approved for newborns and infants under 11 pounds, filling a major gap in care.

The prevalence of long COVID-typical symptom clusters was relatively high among a cohort of adults 2 years after initial COVID-19 infection.

There has been nationwide total of 1,267 confirmed cases of measles this year, with Kentucky being the latest state to announce an outbreak.

The FDA has approved Tyzavan, a novel ready-to-infuse, room temperature stable formulation of vancomycin, for the treatment of various bacterial infections.

Kraft Heinz Foods is recalling some 370,000 pounds of fully cooked turkey bacon products that may be contaminated with listeria.

The risk for severe RSV-related outcomes was effectively reduced among children and infants who received nirsevimab in real-world clinical settings.

Several medical organizations are suing the HHS and Secretary Robert F. Kennedy Jr based on recent actions resulting in significant changes in vaccine policy in the US.

The COVID-19 pandemic yielded indirect increases in disease burden for specific causes, including mental health disorders.

Adults as young as 50 may now qualify for an RSV vaccine if they have certain health conditions, according to a recent CDC update.